{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:04:57Z","timestamp":1789535097257,"version":"build-2803163510"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Background<\/jats:title>\n Diabetic foot infection (DFI) is a major cause of non-traumatic lower-limb amputation and is associated with poor survival outcomes. Identifying therapies that reduce progression to amputation is critical.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the association between statin therapy and risk of amputation in patients with DFI, including assessment of dose-response effects.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A retrospective cohort study involving 376 patients presenting with DFI at a university hospital in Jordan between January 2020 and April 2024. The primary outcome was amputation severity (no amputation, minor amputation, major amputation), analyzed using multivariable ordinal logistic regression, adjusting for potential confounders; major amputation incidence was also examined as a secondary binary outcome for absolute risk reduction and number-needed-to-treat calculations.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Moderate-intensity statin therapy was associated with an absolute risk reduction (ARR) of 9.3% (NNT\u00a0=\u00a011) for major amputation, while high-intensity therapy was associated with an ARR of 14.3% (NNT\u00a0=\u00a07). In adjusted ordinal logistic regression models, both moderate-intensity (aOR 0.43, 95% CI 0.20\u20130.74, p = 0.004) and high-intensity statins (aOR 0.43, 95% CI 0.26\u20130.71, p = 0.001) were associated with lower odds of more severe amputation. A significant dose\u2013response trend was observed, with major amputation rates decreasing from 21.9% in untreated patients to 12.6% and 7.6% in moderate- and high-intensity groups, respectively (p = 0.025). Subgroup analyses showed consistent associations across key clinical subgroups, including patients with advanced Wagner grades, peripheral arterial disease, and neuropathy.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Statin therapy was associated with lower odds of more severe amputation and a lower observed risk of major amputation in patients with diabetic foot infection. An ordered trend in risk reduction was observed across statin intensity levels, but moderate- and high-intensity statins did not differ significantly from one another, so these findings support an association with statin use rather than a confirmed dose-dependent gradient. Further randomized controlled trials are needed to confirm causality and evaluate long-term outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2026.1922755","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:35:20Z","timestamp":1789533320000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of statin therapy on amputation risk in patients with diabetic foot infection: a retrospective cohort study from Jordan"],"prefix":"10.3389","volume":"17","author":[{"given":"Jana","family":"Abdallah","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mera A.","family":"Ababneh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan S.","family":"Jarab","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Ayoub","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasan","family":"Khwaileh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada A.","family":"Alsaleh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","unstructured":"Idf Diabetes Atlas 2025 | Global Diabetes Data & Insights\n \n 2025"},{"key":"B2","unstructured":"Diabetes in the Middle East & North Africa | IDF Diabetes Atlas\n \n 2026"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77970-7","article-title":"Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050","volume":"10","author":"Awad","year":"2020","journal-title":"Sci Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis \u2020","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/DC05-2425","article-title":"Risk factors for foot infections in individuals with diabetes","volume":"29","author":"Lavery","year":"2006","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.293.2.217","article-title":"Preventing foot ulcers in patients with diabetes","volume":"293","author":"Singh","year":"2005","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/FSURG.2021.655902","article-title":"Major amputation profoundly increases mortality in patients with diabetic foot infection","volume":"8","author":"Vuorlaakso","year":"2021","journal-title":"Front Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2007.03.022","article-title":"Statins may be useful in diabetic foot ulceration treatment and prevention","volume":"69","author":"Gulcan","year":"2007","journal-title":"Med Hypotheses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/79510","article-title":"The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals","volume":"6","author":"Kureishi","year":"2000","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116192","article-title":"Advances in the molecular mechanisms of statins in regulating endothelial nitric oxide bioavailability: Interlocking biology between eNOS activity and L-arginine metabolism","volume":"171","author":"Chen","year":"2024","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2008.01.005","article-title":"Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes","volume":"57","author":"Bitto","year":"2008","journal-title":"Pharmacol Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/1120672120922444","article-title":"Statin reduces the incidence of diabetic retinopathy and its need for intervention: A systematic review and meta-analysis","volume":"31","author":"Pranata","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.26355\/EURREV_202311_34339","article-title":"Statin therapy for patients with diabetic nephropathy: balance between safety and efficacy of statin treatment for patients with impaired kidney function","volume":"27","author":"Jairoun","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7717\/PEERJ.3952\/SUPP-1","article-title":"Statins: Antimicrobial resistance breakers or makers","volume":"2017","author":"Ko","year":"2017","journal-title":"PeerJ"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011578","article-title":"The effects of statin therapy on mortality in patients with sepsis: A meta-analysis of randomized trials","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12544","article-title":"Statin use and clinical outcomes among pneumonia patients","volume":"20","author":"Chung","year":"2014","journal-title":"Clin Microbiol Infection"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/WRR.12400","article-title":"Statins may be associated with six-week diabetic foot ulcer healing","volume":"24","author":"Fox","year":"2016","journal-title":"Wound Repair Regener"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/S40842-024-00175-8","article-title":"The impact of statin therapy on the healing of diabetic foot ulcers: a case-control series","volume":"10","author":"O\u2019Dell","year":"2024","journal-title":"Clin Diabetes Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/J.1753-0407.2009.00031.X","article-title":"Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial","volume":"1","author":"Johansen","year":"2009","journal-title":"J Diabetes"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.12968\/JOWC.2022.31.SUP2.S36","article-title":"The impact of statins on wound healing: an ally in treating the highly comorbid patient","volume":"31","author":"Abu El Hawa","year":"2022","journal-title":"J Wound Care"},{"key":"B22","first-page":"41","article-title":"Prediction of wound healing in diabetic foot ulcers: an observational study in tertiary hospital in Indonesia","volume":"49","author":"Soewondo","year":"2017","journal-title":"Acta Med Indones"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/J.JVS.2013.06.069","article-title":"Statin use and lower extremity amputation risk in nonelderly diabetic patients","volume":"58","author":"Sohn","year":"2013","journal-title":"J Vasc Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/DC15-2376","article-title":"Association of statin use and reduced risk of lower-extremity amputation among patients with diabetes: A nationwide population-based cohort observation","volume":"39","author":"Yang","year":"2016","journal-title":"Diabetes Care"},{"key":"B25","first-page":"196","article-title":"Previous atorvastatin treatment and risk of diabetic foot infection in adult patients: a case-control study","volume":"29","author":"Nassaji","year":"2017","journal-title":"Wounds"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/DMRR.3646","article-title":"Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)","volume":"40","author":"Wukich","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/DMRR.3654","article-title":"Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update)","volume":"40","author":"van Netten","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2005.07.002","article-title":"Toward immunomodulatory and anti-inflammatory properties of statins","volume":"15","author":"Arnaud","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/JCI9639","article-title":"Neuroprotection mediated by changes in the endothelial actin cytoskeleton","volume":"106","author":"Laufs","year":"2000","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/NRD1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.12998\/WJCC.V9.I33.10198","article-title":"Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data","volume":"9","author":"Min","year":"2021","journal-title":"World J Clin cases"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1922755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:35:29Z","timestamp":1789533329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1922755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":32,"alternative-id":["10.3389\/fendo.2026.1922755"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1922755","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1922755"}}